How CONNEQT Health’s Pulse Sales and Pricing Shift Could Reshape Cardiovascular Care

• Pulse device sales grow ~50% quarter-on-quarter, annualised revenue run-rate exceeds US$3.5 million
• New pricing model reduces Pulse device price to US$249, introduces in-app purchases and Care+ membership
• Secured A$1.1 million Phase 2b US clinical trial contract for vascular assessment across 30 sites
• Operational restructuring cuts annualised cost base by ~30%, closing cash at A$2.7 million